Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 4 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 7 days agoThe vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 6 days agoAfrica, Senegal and Tunisia to target diseases such as tuberculosis, rift valley fever and...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 5 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 3 days agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE ...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 4 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA ...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 7 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
The chicken and egg problem of fighting another flu pandemic
Billings Gazette· 3 days ago“It’s almost comical to be using a 1940s technology for a 21st-century pandemic,” said Rick Bright,...
Dolly Parton Wants to Take You Back in Time With the Dolly Parton Experience
Cosmopolitan via Yahoo News· 3 days agoDolly Parton sat down with Cosmopolitan to talk about Dollywood's new The Dolly Parton Experience,...
Why This Biotech Stock Crashed 67% To A Two-Year Low
Investor's Business Daily· 3 days agoThe drug, BMF-291, was in early-stage testing for patients with type 1 and type 2 diabetes. The FDA noted there were possible drug-related liver...